The African Continent Ramps Up Efforts To Crack the Code on Outbreaks
Illumina is enhancing genomics capacity in Africa through significant contributions, having donated over $9 million in sequencing systems, reagents, and training over the past two years.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Illumina is enhancing genomics capacity in Africa through significant contributions, having donated over $9 million in sequencing systems, reagents, and training over the past two years. This initiative, part of the Africa Pathogen Genomics Initiative, aims to address public health challenges by improving the ability to analyze genomic sequences, crucial for identifying pathogens and their mutations. Before the pandemic, only seven African nations had adequate national laboratories for such analyses. The COVID-19 pandemic highlighted the urgent need for improved genomics capacity, prompting this partnership.
Positive
- Donation of over $9 million to improve genomics capacity in Africa.
- Partnership with the Africa Pathogen Genomics Initiative to enhance public health.
- Increase in laboratories capable of genomic analysis in African countries.
Negative
- None.
Details
News Market Reaction – ILMN
The recorded move for ILMN in the trading session of this news was +0.86%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NORTHAMPTON, MA / ACCESSWIRE / April 17, 2023 / Illumina
Samuel Oyola, senior scientist and head of genomics at Nairobi's International Livestock Research Institute, near a vat used for long-term storage of specimen samples. Photo by: Sara Jerving / Devex
By Sara Jerving
On a recent afternoon in Nairobi, Kenya, about two dozen scientists gathered, peering at a screen that to the untrained eye looked like gibberish - rows of letters but no coherent words.
The scientists were attending a training to advance skills in the analysis of genomic sequences - a process where the genetic code of an organism is turned into data which reveals information about its characteristics. It's an important technique in public health to determine what pathogen is inflicting a community and whether it's mutating.
Before the COVID-19 pandemic, only seven African countries had national laboratories equipped to do this. But the need to identify new variants of the virus that causes COVID-19 forced laboratories to ramp up this expertise in an unprecedented way.
During the first year of the pandemic, the Africa Pathogen Genomics Initiative was launched as a partnership to close gaps in genomics capacity. As part of that partnership, over the past two years, American biotechnology company Illumina donated over
Continue reading the full article here
View additional multimedia and more ESG storytelling from Illumina on 3blmedia.com.
Contact Info:
Spokesperson: Illumina
Website: https://www.3blmedia.com/profiles/illumina
Email: info@3blmedia.com
SOURCE: Illumina
View source version on accesswire.com:
https://www.accesswire.com/749520/The-African-Continent-Ramps-Up-Efforts-To-Crack-the-Code-on-Outbreaks
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.